0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Animal Antibiotics and Antimicrobials - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-22B7779
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Animal Antibiotics and Antimicrobials Market Insights and Forecast to 2028
BUY CHAPTERS

Animal Antibiotics and Antimicrobials - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-22B7779
Report
October 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Animal Antibiotics and Antimicrobials - Market Size

The global market for Animal Antibiotics and Antimicrobials was estimated to be worth US$ 3934.2 million in 2023 and is forecast to a readjusted size of US$ 4840.5 million by 2030 with a CAGR of 2.6% during the forecast period 2024-2030

Animal Antibiotics and Antimicrobials - Market

Animal Antibiotics and Antimicrobials - Market

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 25%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Animal Antibiotics and Antimicrobials, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Animal Antibiotics and Antimicrobials by region & country, by Type, and by Application.
The Animal Antibiotics and Antimicrobials market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Antibiotics and Antimicrobials.
Market Segmentation

Scope of Animal Antibiotics and Antimicrobials - Market Report

Report Metric Details
Report Name Animal Antibiotics and Antimicrobials - Market
Forecasted market size in 2030 US$ 4840.5 million
CAGR 2.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Etracyclines
  • Penicillins
  • Macrolides
  • Aminoglycosides
  • Sulfonamides
  • Fluoroquinolones
  • Lincosamides
  • Cephalosporins
  • Others
Segment by Application
  • Food-producing Animals
  • Companion Animals
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zoetis, Inc., Merck & Co., Inc., Eli Lilly and Company, Bayer AG, Virbac, Boehringer Ingelheim GmbH, Sanofi, Ceva Sante Animale, Vetoquinol S.A., Dechra Pharmaceuticals PLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Animal Antibiotics and Antimicrobials manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Animal Antibiotics and Antimicrobials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Animal Antibiotics and Antimicrobials in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Animal Antibiotics and Antimicrobials - Market size in 2030?

Ans: The Animal Antibiotics and Antimicrobials - Market size in 2030 will be US$ 4840.5 million.

Who are the main players in the Animal Antibiotics and Antimicrobials - Market report?

Ans: The main players in the Animal Antibiotics and Antimicrobials - Market are Zoetis, Inc., Merck & Co., Inc., Eli Lilly and Company, Bayer AG, Virbac, Boehringer Ingelheim GmbH, Sanofi, Ceva Sante Animale, Vetoquinol S.A., Dechra Pharmaceuticals PLC

What are the Application segmentation covered in the Animal Antibiotics and Antimicrobials - Market report?

Ans: The Applications covered in the Animal Antibiotics and Antimicrobials - Market report are Food-producing Animals, Companion Animals

What are the Type segmentation covered in the Animal Antibiotics and Antimicrobials - Market report?

Ans: The Types covered in the Animal Antibiotics and Antimicrobials - Market report are Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins, Others

1 Market Overview
1.1 Animal Antibiotics and Antimicrobials Product Introduction
1.2 Global Animal Antibiotics and Antimicrobials Market Size Forecast
1.3 Animal Antibiotics and Antimicrobials Market Trends & Drivers
1.3.1 Animal Antibiotics and Antimicrobials Industry Trends
1.3.2 Animal Antibiotics and Antimicrobials Market Drivers & Opportunity
1.3.3 Animal Antibiotics and Antimicrobials Market Challenges
1.3.4 Animal Antibiotics and Antimicrobials Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal Antibiotics and Antimicrobials Players Revenue Ranking (2023)
2.2 Global Animal Antibiotics and Antimicrobials Revenue by Company (2019-2024)
2.3 Key Companies Animal Antibiotics and Antimicrobials Manufacturing Base Distribution and Headquarters
2.4 Key Companies Animal Antibiotics and Antimicrobials Product Offered
2.5 Key Companies Time to Begin Mass Production of Animal Antibiotics and Antimicrobials
2.6 Animal Antibiotics and Antimicrobials Market Competitive Analysis
2.6.1 Animal Antibiotics and Antimicrobials Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Animal Antibiotics and Antimicrobials Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Antibiotics and Antimicrobials as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Etracyclines
3.1.2 Penicillins
3.1.3 Macrolides
3.1.4 Aminoglycosides
3.1.5 Sulfonamides
3.1.6 Fluoroquinolones
3.1.7 Lincosamides
3.1.8 Cephalosporins
3.1.9 Others
3.2 Global Animal Antibiotics and Antimicrobials Sales Value by Type
3.2.1 Global Animal Antibiotics and Antimicrobials Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal Antibiotics and Antimicrobials Sales Value, by Type (2019-2030)
3.2.3 Global Animal Antibiotics and Antimicrobials Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food-producing Animals
4.1.2 Companion Animals
4.2 Global Animal Antibiotics and Antimicrobials Sales Value by Application
4.2.1 Global Animal Antibiotics and Antimicrobials Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal Antibiotics and Antimicrobials Sales Value, by Application (2019-2030)
4.2.3 Global Animal Antibiotics and Antimicrobials Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Animal Antibiotics and Antimicrobials Sales Value by Region
5.1.1 Global Animal Antibiotics and Antimicrobials Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal Antibiotics and Antimicrobials Sales Value by Region (2019-2024)
5.1.3 Global Animal Antibiotics and Antimicrobials Sales Value by Region (2025-2030)
5.1.4 Global Animal Antibiotics and Antimicrobials Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
5.2.2 North America Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
5.3.2 Europe Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
5.4.2 Asia Pacific Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
5.5.2 South America Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
5.6.2 Middle East & Africa Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal Antibiotics and Antimicrobials Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal Antibiotics and Antimicrobials Sales Value
6.3 United States
6.3.1 United States Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
6.3.2 United States Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal Antibiotics and Antimicrobials Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
6.4.2 Europe Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal Antibiotics and Antimicrobials Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
6.5.2 China Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal Antibiotics and Antimicrobials Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
6.6.2 Japan Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal Antibiotics and Antimicrobials Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
6.7.2 South Korea Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal Antibiotics and Antimicrobials Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
6.8.2 Southeast Asia Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal Antibiotics and Antimicrobials Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal Antibiotics and Antimicrobials Sales Value, 2019-2030
6.9.2 India Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal Antibiotics and Antimicrobials Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis, Inc.
7.1.1 Zoetis, Inc. Profile
7.1.2 Zoetis, Inc. Main Business
7.1.3 Zoetis, Inc. Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.1.4 Zoetis, Inc. Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.1.5 Zoetis, Inc. Recent Developments
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Profile
7.2.2 Merck & Co., Inc. Main Business
7.2.3 Merck & Co., Inc. Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.2.4 Merck & Co., Inc. Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.2.5 Merck & Co., Inc. Recent Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Profile
7.3.2 Eli Lilly and Company Main Business
7.3.3 Eli Lilly and Company Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.3.4 Eli Lilly and Company Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.3.5 Bayer AG Recent Developments
7.4 Bayer AG
7.4.1 Bayer AG Profile
7.4.2 Bayer AG Main Business
7.4.3 Bayer AG Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.4.4 Bayer AG Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.4.5 Bayer AG Recent Developments
7.5 Virbac
7.5.1 Virbac Profile
7.5.2 Virbac Main Business
7.5.3 Virbac Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.5.4 Virbac Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.5.5 Virbac Recent Developments
7.6 Boehringer Ingelheim GmbH
7.6.1 Boehringer Ingelheim GmbH Profile
7.6.2 Boehringer Ingelheim GmbH Main Business
7.6.3 Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.6.4 Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.6.5 Boehringer Ingelheim GmbH Recent Developments
7.7 Sanofi
7.7.1 Sanofi Profile
7.7.2 Sanofi Main Business
7.7.3 Sanofi Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.7.4 Sanofi Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.7.5 Sanofi Recent Developments
7.8 Ceva Sante Animale
7.8.1 Ceva Sante Animale Profile
7.8.2 Ceva Sante Animale Main Business
7.8.3 Ceva Sante Animale Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.8.4 Ceva Sante Animale Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.8.5 Ceva Sante Animale Recent Developments
7.9 Vetoquinol S.A.
7.9.1 Vetoquinol S.A. Profile
7.9.2 Vetoquinol S.A. Main Business
7.9.3 Vetoquinol S.A. Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.9.4 Vetoquinol S.A. Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.9.5 Vetoquinol S.A. Recent Developments
7.10 Dechra Pharmaceuticals PLC
7.10.1 Dechra Pharmaceuticals PLC Profile
7.10.2 Dechra Pharmaceuticals PLC Main Business
7.10.3 Dechra Pharmaceuticals PLC Animal Antibiotics and Antimicrobials Products, Services and Solutions
7.10.4 Dechra Pharmaceuticals PLC Animal Antibiotics and Antimicrobials Revenue (US$ Million) & (2019-2024)
7.10.5 Dechra Pharmaceuticals PLC Recent Developments
8 Industry Chain Analysis
8.1 Animal Antibiotics and Antimicrobials Industrial Chain
8.2 Animal Antibiotics and Antimicrobials Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal Antibiotics and Antimicrobials Sales Model
8.5.2 Sales Channel
8.5.3 Animal Antibiotics and Antimicrobials Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Animal Antibiotics and Antimicrobials Market Trends
    Table 2. Animal Antibiotics and Antimicrobials Market Drivers & Opportunity
    Table 3. Animal Antibiotics and Antimicrobials Market Challenges
    Table 4. Animal Antibiotics and Antimicrobials Market Restraints
    Table 5. Global Animal Antibiotics and Antimicrobials Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Animal Antibiotics and Antimicrobials Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Animal Antibiotics and Antimicrobials Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Animal Antibiotics and Antimicrobials Product Type
    Table 9. Key Companies Time to Begin Mass Production of Animal Antibiotics and Antimicrobials
    Table 10. Global Animal Antibiotics and Antimicrobials Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Antibiotics and Antimicrobials as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Animal Antibiotics and Antimicrobials Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Animal Antibiotics and Antimicrobials Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Animal Antibiotics and Antimicrobials Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Animal Antibiotics and Antimicrobials Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Animal Antibiotics and Antimicrobials Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Animal Antibiotics and Antimicrobials Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Animal Antibiotics and Antimicrobials Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Animal Antibiotics and Antimicrobials Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Animal Antibiotics and Antimicrobials Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Animal Antibiotics and Antimicrobials Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Animal Antibiotics and Antimicrobials Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Animal Antibiotics and Antimicrobials Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Animal Antibiotics and Antimicrobials Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Animal Antibiotics and Antimicrobials Sales Value by Region (2019-2024) & (%)
    Table 27. Global Animal Antibiotics and Antimicrobials Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Animal Antibiotics and Antimicrobials Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Animal Antibiotics and Antimicrobials Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Animal Antibiotics and Antimicrobials Sales Value, (2025-2030) & (US$ Million)
    Table 31. Zoetis, Inc. Basic Information List
    Table 32. Zoetis, Inc. Description and Business Overview
    Table 33. Zoetis, Inc. Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Zoetis, Inc. (2019-2024)
    Table 35. Zoetis, Inc. Recent Developments
    Table 36. Merck & Co., Inc. Basic Information List
    Table 37. Merck & Co., Inc. Description and Business Overview
    Table 38. Merck & Co., Inc. Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Merck & Co., Inc. (2019-2024)
    Table 40. Merck & Co., Inc. Recent Developments
    Table 41. Eli Lilly and Company Basic Information List
    Table 42. Eli Lilly and Company Description and Business Overview
    Table 43. Eli Lilly and Company Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Eli Lilly and Company (2019-2024)
    Table 45. Eli Lilly and Company Recent Developments
    Table 46. Bayer AG Basic Information List
    Table 47. Bayer AG Description and Business Overview
    Table 48. Bayer AG Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Bayer AG (2019-2024)
    Table 50. Bayer AG Recent Developments
    Table 51. Virbac Basic Information List
    Table 52. Virbac Description and Business Overview
    Table 53. Virbac Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Virbac (2019-2024)
    Table 55. Virbac Recent Developments
    Table 56. Boehringer Ingelheim GmbH Basic Information List
    Table 57. Boehringer Ingelheim GmbH Description and Business Overview
    Table 58. Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Boehringer Ingelheim GmbH (2019-2024)
    Table 60. Boehringer Ingelheim GmbH Recent Developments
    Table 61. Sanofi Basic Information List
    Table 62. Sanofi Description and Business Overview
    Table 63. Sanofi Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Sanofi (2019-2024)
    Table 65. Sanofi Recent Developments
    Table 66. Ceva Sante Animale Basic Information List
    Table 67. Ceva Sante Animale Description and Business Overview
    Table 68. Ceva Sante Animale Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Ceva Sante Animale (2019-2024)
    Table 70. Ceva Sante Animale Recent Developments
    Table 71. Vetoquinol S.A. Basic Information List
    Table 72. Vetoquinol S.A. Description and Business Overview
    Table 73. Vetoquinol S.A. Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Vetoquinol S.A. (2019-2024)
    Table 75. Vetoquinol S.A. Recent Developments
    Table 76. Dechra Pharmaceuticals PLC Basic Information List
    Table 77. Dechra Pharmaceuticals PLC Description and Business Overview
    Table 78. Dechra Pharmaceuticals PLC Animal Antibiotics and Antimicrobials Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Animal Antibiotics and Antimicrobials Business of Dechra Pharmaceuticals PLC (2019-2024)
    Table 80. Dechra Pharmaceuticals PLC Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Animal Antibiotics and Antimicrobials Downstream Customers
    Table 84. Animal Antibiotics and Antimicrobials Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Animal Antibiotics and Antimicrobials Product Picture
    Figure 2. Global Animal Antibiotics and Antimicrobials Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Animal Antibiotics and Antimicrobials Sales Value (2019-2030) & (US$ Million)
    Figure 4. Animal Antibiotics and Antimicrobials Report Years Considered
    Figure 5. Global Animal Antibiotics and Antimicrobials Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Animal Antibiotics and Antimicrobials Revenue in 2023
    Figure 7. Animal Antibiotics and Antimicrobials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Etracyclines Picture
    Figure 9. Penicillins Picture
    Figure 10. Macrolides Picture
    Figure 11. Aminoglycosides Picture
    Figure 12. Sulfonamides Picture
    Figure 13. Fluoroquinolones Picture
    Figure 14. Lincosamides Picture
    Figure 15. Cephalosporins Picture
    Figure 16. Others Picture
    Figure 17. Global Animal Antibiotics and Antimicrobials Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Animal Antibiotics and Antimicrobials Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Product Picture of Food-producing Animals
    Figure 20. Product Picture of Companion Animals
    Figure 21. Global Animal Antibiotics and Antimicrobials Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Animal Antibiotics and Antimicrobials Sales Value Market Share by Application, 2023 & 2030
    Figure 23. North America Animal Antibiotics and Antimicrobials Sales Value (2019-2030) & (US$ Million)
    Figure 24. North America Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
    Figure 25. Europe Animal Antibiotics and Antimicrobials Sales Value (2019-2030) & (US$ Million)
    Figure 26. Europe Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
    Figure 27. Asia Pacific Animal Antibiotics and Antimicrobials Sales Value (2019-2030) & (US$ Million)
    Figure 28. Asia Pacific Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
    Figure 29. South America Animal Antibiotics and Antimicrobials Sales Value (2019-2030) & (US$ Million)
    Figure 30. South America Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
    Figure 31. Middle East & Africa Animal Antibiotics and Antimicrobials Sales Value (2019-2030) & (US$ Million)
    Figure 32. Middle East & Africa Animal Antibiotics and Antimicrobials Sales Value by Country (%), 2023 VS 2030
    Figure 33. Key Countries/Regions Animal Antibiotics and Antimicrobials Sales Value (%), (2019-2030)
    Figure 34. United States Animal Antibiotics and Antimicrobials Sales Value, (2019-2030) & (US$ Million)
    Figure 35. United States Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
    Figure 36. United States Animal Antibiotics and Antimicrobials Sales Value by Application (%), 2023 VS 2030
    Figure 37. Europe Animal Antibiotics and Antimicrobials Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Europe Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
    Figure 39. Europe Animal Antibiotics and Antimicrobials Sales Value by Application (%), 2023 VS 2030
    Figure 40. China Animal Antibiotics and Antimicrobials Sales Value, (2019-2030) & (US$ Million)
    Figure 41. China Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
    Figure 42. China Animal Antibiotics and Antimicrobials Sales Value by Application (%), 2023 VS 2030
    Figure 43. Japan Animal Antibiotics and Antimicrobials Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Japan Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
    Figure 45. Japan Animal Antibiotics and Antimicrobials Sales Value by Application (%), 2023 VS 2030
    Figure 46. South Korea Animal Antibiotics and Antimicrobials Sales Value, (2019-2030) & (US$ Million)
    Figure 47. South Korea Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
    Figure 48. South Korea Animal Antibiotics and Antimicrobials Sales Value by Application (%), 2023 VS 2030
    Figure 49. Southeast Asia Animal Antibiotics and Antimicrobials Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
    Figure 51. Southeast Asia Animal Antibiotics and Antimicrobials Sales Value by Application (%), 2023 VS 2030
    Figure 52. India Animal Antibiotics and Antimicrobials Sales Value, (2019-2030) & (US$ Million)
    Figure 53. India Animal Antibiotics and Antimicrobials Sales Value by Type (%), 2023 VS 2030
    Figure 54. India Animal Antibiotics and Antimicrobials Sales Value by Application (%), 2023 VS 2030
    Figure 55. Animal Antibiotics and Antimicrobials Industrial Chain
    Figure 56. Animal Antibiotics and Antimicrobials Manufacturing Cost Structure
    Figure 57. Channels of Distribution (Direct Sales, and Distribution)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS